| Zygomycosis in the immunocompromised patient: a case report. | |
| | |
MedLine Citation:
|
PMID: 16918059 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Zygomycosis is a highly aggressive infection observed in immunocompromised patients, such as those with haematological malignancies. The sites most frequently involved are the sinuses and the lungs. New diagnostic tools and new antifungal treatments are essential in order to diagnose early and treat efficiently infections due to moulds. We report a case of sinusitis due to Absidia corymbifera occurring during chemotherapy-induced bone marrow aplasia in a patient with acute leukaemia. The sinusitis was successfully treated with AmBisome, and surgical debridement. |
| | |
Authors:
|
Aspasia Georgala; Marc Vekemans; Mireille Husson; Nathalie Meuleman; Hugues Beguin; Nicole Nolard; Mickael Aoun |
Related Documents
:
|
11227849 - Esophageal candidiasis in non-immune suppressed patients in a semi-urban town, southern... 2005939 - Detection of circulating candida enolase by immunoassay in patients with cancer and inv... 11112669 - Travel-associated burkholderia pseudomallei infection (melioidosis) in a patient with c... 6990879 - Proteus vulgaris agglutination by cystic fibrosis sera. 12127859 - Recent progress in the diagnosis of fungal infections in the immunocompromised host. 11545239 - Post-antifungal effect of polyene, azole and dna-analogue agents against oral candida a... 8276349 - Hepatitis c virus genotypes: an investigation of type-specific differences in geographi... 9815239 - Variability in repeated consecutive measurements of plasma human immunodeficiency virus... 21164149 - Impact of hiv testing on sexual health communication in south africa. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Acta bio-medica : Atenei Parmensis Volume: 77 Suppl 2 ISSN: 0392-4203 ISO Abbreviation: - Publication Date: 2006 |
Date Detail:
|
Created Date: 2006-08-21 Completed Date: 2006-12-04 Revised Date: 2008-09-25 |
Medline Journal Info:
|
Nlm Unique ID: 101295064 Medline TA: Acta Biomed Country: Italy |
Other Details:
|
Languages: eng Pagination: 5-9 Citation Subset: IM |
Affiliation:
|
Infectious Disease Department, Jules Bordet Institute, Brussels, Belgium. nathalie.cardinal@bordet.be |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Absidia
/
isolation & purification* Acute Disease Aerosols Amphotericin B / administration & dosage, therapeutic use* Amsacrine / administration & dosage Antibiotic Prophylaxis Antifungal Agents / administration & dosage, therapeutic use* Antineoplastic Combined Chemotherapy Protocols / therapeutic use Combined Modality Therapy Cytarabine / administration & dosage Daunorubicin / administration & dosage Debridement Drug Resistance, Fungal Drug Resistance, Neoplasm Etoposide / administration & dosage Fluconazole / therapeutic use Humans Immunocompromised Host Leukemia / complications, drug therapy Liposomes Middle Aged Mucormycosis / drug therapy*, microbiology, surgery Sinusitis / drug therapy*, microbiology, radiography, surgery Tomography, X-Ray Computed |
| Chemical | |
Reg. No./Substance:
|
0/Aerosols; 0/Antifungal Agents; 0/Liposomes; 0/liposomal amphotericin B; 1397-89-3/Amphotericin B; 147-94-4/Cytarabine; 20830-81-3/Daunorubicin; 33419-42-0/Etoposide; 51264-14-3/Amsacrine; 86386-73-4/Fluconazole |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A case of pelvic bone hydatidosis--diagnosis and treatment.
Next Document: Disseminated invasive aspergillosis in a patient with acute leukaemia.